Cargando…
Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond
Increasing attention has focused on efforts to promote the biological activities of high-density lipoproteins (HDL) in order to reduce cardiovascular risk. Targeting apolipoprotein A-I (apoA-I), the major protein carried on HDL particles, represents an attractive approach to promoting HDL by virtue...
Autores principales: | Di Bartolo, Belinda A., Scherer, Daniel J., Nicholls, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108390/ https://www.ncbi.nlm.nih.gov/pubmed/27904522 http://dx.doi.org/10.5114/aoms.2016.62906 |
Ejemplares similares
-
Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2016) -
Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023) -
Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008) -
Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging
por: Di Giovanni, Giuseppe, et al.
Publicado: (2022) -
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
por: Tada, Hayato, et al.
Publicado: (2021)